Gabrionix ER-300 Tablets are a pharmaceutical formulation featuring a revolutionary gastro-retentive extended-release system that provides up to 24-hour pain control. The controlled gastric release of gabapentin allows sustained drug exposure, improved absorption, predictable dose proportionality, and faster achievement of therapeutic levels. This results in effective and well-tolerated management of neuropathic pain and seizure disorders.
Gabrionix ER-300 Tablets are a pharmaceutical formulation featuring a revolutionary gastro-retentive extended-release system that provides up to 24-hour pain control. The controlled gastric release of gabapentin allows sustained drug exposure, improved absorption, predictable dose proportionality, and faster achievement of therapeutic levels. This results in effective and well-tolerated management of neuropathic pain and seizure disorders.
Partial seizures (adjunct therapy) Neuropathic pain (diabetic neuropathy, postherpetic neuralgia) Fibromyalgia Restless leg syndrome and sleep disturbances Anxiety disorders (off-label use) Migraine prophylaxis Hot flashes and menopausal symptoms Support in alcohol and opioid withdrawal
Dosage should be taken as prescribed by the physician.
Gabapentin (Extended Release) – 300 mg
Gabapentin ER (300 mg) Utilizes a gastro-retentive extended-release system providing sustained drug release in the stomach for up to ~18 hours Minimizes L-amino acid transporter (LAT) saturation, improving absorption efficiency Offers better bioavailability and dose proportionality compared to immediate-release formulations Enables earlier onset of therapeutic effect, often noticeable by Day 2 Allows faster and smoother titration to the therapeutic dose with improved tolerability Overall Effect: This advanced delivery system ensures steady plasma levels, enhanced clinical response, and long-lasting pain and seizure control.
